Loading…
Based on limited available metadata, this FDA Warning Letter issued to LEC Custom Products, Inc. on September 24, 2020, concerns drug manufacturing or distribution operations. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined, though Warning Letters typically address significant compliance issues such as manufacturing defects, quality control failures, or labeling problems. The warning falls under FDA's drug regulatory jurisdiction and represents a formal enforcement action requiring corrective action by the company.